Variant	variant	O	O
ventricular	ventricular	O	B_disease
tachycardia	tachycardia	O	S_disease
in	in	O	O
desipramine	desipramine	S_chemicals	O
toxicity	toxicity	O	O
.	.	O	O

We	we	O	O
report	report	O	O
a	a	O	O
case	case	O	O
of	of	O	O
variant	variant	O	O
ventricular	ventricular	O	B_disease
tachycardia	tachycardia	O	S_disease
induced	induced	O	O
by	by	O	O
desipramine	desipramine	S_chemicals	O
toxicity	toxicity	O	O
.	.	O	O

Unusual	unusual	O	O
features	features	O	O
of	of	O	O
the	the	O	O
arrhythmia	arrhythmia	O	S_disease
are	are	O	O
repetitive	repetitive	O	O
group	group	O	O
beating	beating	O	O
,	,	O	O
progressive	progressive	O	O
shortening	shortening	O	O
of	of	O	O
the	the	O	O
R-R	r-r	O	O
interval	interval	O	O
,	,	O	O
progressive	progressive	O	O
widening	widening	O	O
of	of	O	O
the	the	O	O
QRS	qrs	O	O
complex	complex	O	O
with	with	O	O
eventual	eventual	O	O
failure	failure	O	O
of	of	O	O
intraventricular	intraventricular	O	O
conduction	conduction	O	O
,	,	O	O
and	and	O	O
changes	changes	O	O
in	in	O	O
direction	direction	O	O
of	of	O	O
the	the	O	O
QRS	qrs	O	O
axis	axis	O	O
.	.	O	O

Recognition	recognition	O	O
of	of	O	O
variant	variant	O	O
ventricular	ventricular	O	B_disease
tachycardia	tachycardia	O	S_disease
is	is	O	O
important	important	O	O
because	because	O	O
therapy	therapy	O	O
differs	differs	O	O
from	from	O	O
that	that	O	O
of	of	O	O
classic	classic	O	O
ventricular	ventricular	O	B_disease
tachycardia	tachycardia	O	S_disease
.	.	O	O

